Associate Professor of Medicine Duke University Health Duke University Health Durham, North Carolina, United States
Sponsored by Novo Nordisk.
Program
Description: Join us as we discuss the importance of early identification of MASH (metabolic dysfunction-associated steatohepatitis), including how to accurately identify and select patients who are at risk for clinically significant fibrosis. We will also discuss clinical trial data for patients with MASH and stage 2 or 3 fibrosis.
.jpg "Amreen Dinani, MD, FRCPC ABOM photo")